Quantum BioPharma Ltd. (QNTM) vs Rein Therapeutics Inc. (RNTX)
A side-by-side comparison of Quantum BioPharma Ltd. and Rein Therapeutics Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
QNTM
Quantum BioPharma Ltd.
$3.09HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
RNTX
Rein Therapeutics Inc.
$0.83HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — QNTM vs RNTX
growth of $100 · dividends reinvested · last 2yQNTM -21.2% (-11.2%/yr)RNTX -61.1% (-37.6%/yr)QNTM compounded faster over this window
QNTM RNTX
QNTM vs RNTX: by the numbers
- •RNTX is the larger company ($23M vs $20M market cap).
Metrics side by side
Valuation
| Metric | QNTM | RNTX |
|---|---|---|
| P/B ratio | 2.49 | 2.26 |
Profitability
| Metric | QNTM | RNTX |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -313.46% | -487.90% |
| ROIC | -27.14% | -36.89% |
Growth (annualized)
| Metric | QNTM | RNTX |
|---|---|---|
| Total return CAGR (5Y) | -49.16% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.